Sangeeta Saxena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sangeeta Saxena has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Anamta Rizvi
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, India
5 shared publications Priyanka Varun
4 shared publications- Sailendra Kumar
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, India
4 shared publications - Monica Sharma
Department of Biotechnology, School of Life Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, India
3 shared publications Priyanka
3 shared publications- Yusuf Akhter
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, India
3 shared publications
Latest Publications
- 24 March 2026
- Published by Springer Nature in Applied Magnetic Resonance
- Vol. 57 (3-4)
Metabolic Characterization of Methanolic Extract of Indian Mustard Microgreens Using High-Resolution 800 MHz NMR Spectroscopy and LC–MS
- 24 March 2026
- Published by Springer Nature in Applied Magnetic Resonance
- Vol. 57 (3-4)
Metabolic Characterization of Methanolic Extract of Indian Mustard Microgreens Using High-Resolution 800 MHz NMR Spectroscopy and LC–MS
- 2 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11696-11711
Leaf miRNAs of Withania somnifera Negatively Regulate the Aging-Associated Genes in C. elegans
Aging is a physiological process that culminates in cellular senescence, a phenomenon that has significant implications for health and longevity. Plant-based therapeutics, particularly the root of Withania somnifera, have been reported to delay the onset and progression of aging and its associated disorders, including Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders. However, the role of leaf-derived microRNAs (miRNAs) from W. somnifera in the molecular regulation of genes involved in aging remains poorly understood. Caenorhabditis elegans serves as an indispensable model organism for studying aging-associated gene regulation due to its short lifespan, conserved human orthologs, and ease of laboratory cultivation. In this study, we explored the regulatory interactions between miRNAs derived from the leaf tissues of W. somnifera and aging-associated genes, utilizing C. elegans as a model organism. We employed bioinformatics to identify miRNAs that interact with aging-associated genes in C. elegans and found that three specific miRNAs in the leaf tissue of W. somnifera interacted with these genes. To assess the physiological effects of these miRNAs on C. elegans, we conducted biochemical assays, including lifespan, chemotaxis, and stress resistance assays. Additionally, we investigated the differential gene expression of the interacting genes in the presence and absence of W. somnifera leaf miRNA treatment using real-time PCR. The results indicated that the expression levels of the age-1 and sel-12 genes were significantly downregulated, while the apl-1 gene was upregulated following treatment with leaf miRNAs in C. elegans. These findings suggest that miRNAs derived from W. somnifera leaves may play a crucial role in regulating aging-associated gene expression. This is the first study, to our knowledge, that identifies the miRNAs of W. somnifera leaf involved in aging-associated gene regulation, thereby paving the way for future research into the therapeutic potential of plant-derived miRNAs in combating age-related disorders.
- 2 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11696-11711
Leaf miRNAs of Withania somnifera Negatively Regulate the Aging-Associated Genes in C. elegans
Aging is a physiological process that culminates in cellular senescence, a phenomenon that has significant implications for health and longevity. Plant-based therapeutics, particularly the root of Withania somnifera, have been reported to delay the onset and progression of aging and its associated disorders, including Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders. However, the role of leaf-derived microRNAs (miRNAs) from W. somnifera in the molecular regulation of genes involved in aging remains poorly understood. Caenorhabditis elegans serves as an indispensable model organism for studying aging-associated gene regulation due to its short lifespan, conserved human orthologs, and ease of laboratory cultivation. In this study, we explored the regulatory interactions between miRNAs derived from the leaf tissues of W. somnifera and aging-associated genes, utilizing C. elegans as a model organism. We employed bioinformatics to identify miRNAs that interact with aging-associated genes in C. elegans and found that three specific miRNAs in the leaf tissue of W. somnifera interacted with these genes. To assess the physiological effects of these miRNAs on C. elegans, we conducted biochemical assays, including lifespan, chemotaxis, and stress resistance assays. Additionally, we investigated the differential gene expression of the interacting genes in the presence and absence of W. somnifera leaf miRNA treatment using real-time PCR. The results indicated that the expression levels of the age-1 and sel-12 genes were significantly downregulated, while the apl-1 gene was upregulated following treatment with leaf miRNAs in C. elegans. These findings suggest that miRNAs derived from W. somnifera leaves may play a crucial role in regulating aging-associated gene expression. This is the first study, to our knowledge, that identifies the miRNAs of W. somnifera leaf involved in aging-associated gene regulation, thereby paving the way for future research into the therapeutic potential of plant-derived miRNAs in combating age-related disorders.
- Open Access
- 5 February 2025
- Published by Elsevier in The Microbe
- Vol. 6
Association of Catharanthus yellow mosaic virus and a novel Tomato leaf curl Lucknow betasatellite with papaya leaf curl disease (PaLCD) in India
- 5 February 2025
- Published by Elsevier in The Microbe
- Vol. 6
Open AccessAssociation of Catharanthus yellow mosaic virus and a novel Tomato leaf curl Lucknow betasatellite with papaya leaf curl disease (PaLCD) in India
- 18 January 2025
- Published by Springer Nature
- p. 47-65
Trailing the Prospects of Leguminous Microgreens as Rising Functional and Future Foods
- 18 January 2025
- Published by Springer Nature
- p. 47-65
Trailing the Prospects of Leguminous Microgreens as Rising Functional and Future Foods
- 7 October 2024
- Published by Springer Nature in 3 Biotech
- Vol. 14 (11) , 1-28
Biotechnological advances in microbial synthesis of gold nanoparticles: Optimizations and applications
This review discusses the eco-friendly and cost-effective biosynthesis of gold nanoparticles (AuNPs) in viable microorganisms, focusing on microbes-mediated AuNP biosynthesis. This process suits agricultural, environmental, and biomedical applications, offering renewable, eco-friendly, non-toxic, sustainable, and time-efficient methods. Microorganisms are increasingly used in green technology, nanotechnology, and RNAi technology, but several microorganisms have not been fully identified and characterized. Bio-nanotechnology offers eco-friendly and sustainable solutions for nanomedicine, with microbe-mediated nanoparticle biosynthesis producing AuNPs with anti-oxidation activity, stability, and biocompatibility. Ultrasmall AuNPs offer rapid distribution, renal clearance, and enhanced permeability in biomedical applications. The review explores nano-size dependent biosynthesis of AuNPs by bacteria, fungi, and viruses revealing their non-toxic, non-genotoxic, and non-oxidative properties on human cells. AuNPs with varying sizes and shapes, from nitrate reductase enzymes, have shown potential as a promising nano-catalyst. The synthesized AuNPs, with negative charge capping molecules, have demonstrated antibacterial activity against drug-resistant Pseudomonas aeruginosa, and Acinetobacter baumannii strains, and were non-toxic to Vero cell lines, indicating potential antibiotic resistance treatments. A green chemical method for the biosynthesis of AuNPs using reducing chloroauric acid and Rhizopus oryzae protein extract has been described, demonstrating excellent stability and strong catalytic activity. AuNPs are eco-friendly, non-toxic, and time-efficient, making them ideal for biomedical applications due to their antioxidant, antidiabetic, and antibacterial properties. In addition to the biomedical application, the review also highlights the role of microbially synthesized AuNPs in sustainable management of plant diseases, and environmental bioremediation.
- 7 October 2024
- Published by Springer Nature in 3 Biotech
- Vol. 14 (11) , 1-28
Biotechnological advances in microbial synthesis of gold nanoparticles: Optimizations and applications
This review discusses the eco-friendly and cost-effective biosynthesis of gold nanoparticles (AuNPs) in viable microorganisms, focusing on microbes-mediated AuNP biosynthesis. This process suits agricultural, environmental, and biomedical applications, offering renewable, eco-friendly, non-toxic, sustainable, and time-efficient methods. Microorganisms are increasingly used in green technology, nanotechnology, and RNAi technology, but several microorganisms have not been fully identified and characterized. Bio-nanotechnology offers eco-friendly and sustainable solutions for nanomedicine, with microbe-mediated nanoparticle biosynthesis producing AuNPs with anti-oxidation activity, stability, and biocompatibility. Ultrasmall AuNPs offer rapid distribution, renal clearance, and enhanced permeability in biomedical applications. The review explores nano-size dependent biosynthesis of AuNPs by bacteria, fungi, and viruses revealing their non-toxic, non-genotoxic, and non-oxidative properties on human cells. AuNPs with varying sizes and shapes, from nitrate reductase enzymes, have shown potential as a promising nano-catalyst. The synthesized AuNPs, with negative charge capping molecules, have demonstrated antibacterial activity against drug-resistant Pseudomonas aeruginosa, and Acinetobacter baumannii strains, and were non-toxic to Vero cell lines, indicating potential antibiotic resistance treatments. A green chemical method for the biosynthesis of AuNPs using reducing chloroauric acid and Rhizopus oryzae protein extract has been described, demonstrating excellent stability and strong catalytic activity. AuNPs are eco-friendly, non-toxic, and time-efficient, making them ideal for biomedical applications due to their antioxidant, antidiabetic, and antibacterial properties. In addition to the biomedical application, the review also highlights the role of microbially synthesized AuNPs in sustainable management of plant diseases, and environmental bioremediation.
- Open Access
- 28 August 2024
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 23, 1068-1070
Opening avenue for the targeted treatment of lung cancer using xanthohumol loaded nanostructured lipid carriers
- 28 August 2024
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 23, 1068-1070
Open AccessOpening avenue for the targeted treatment of lung cancer using xanthohumol loaded nanostructured lipid carriers